Experimental pill extended survival in clinical trial for advanced pancreatic cancer
An experimental pill significantly extended survival in a major clinical trial for advanced pancreatic cancer, according to DailySabah. NPR reported that the pill helped people with advanced pancreatic cancer live longer. Pancreatic cancer has a 13% five-year survival rate, according to Bluesky.
An experimental pill significantly extended survival in a major clinical trial for advanced pancreatic cancer, according to DailySabah. NPR reported that the pill helped people with advanced pancreatic cancer live longer. Pancreatic cancer has a 13% five-year survival rate, according to Bluesky.
This account was written only from facts that survived Augur's
corroboration pass — 0 corroborated across opposed news blocs,
0 contested (attributed to both sides), 3
single-source (attributed). Nothing was added; no significance was inferred.
Model Qwen3-Next-80B-A3B-Instruct.
See the evidence & the verbatim quotes →